Biological sex differences in Alzheimer's preclinical research: A call to action.
Ansley V Watersnull nullMelissa H LaitnerPublished in: Alzheimer's & dementia (New York, N. Y.) (2021)
Previous research supports the idea that better integration of SABV could open new doors in treatment research. We provide examples of best practices and discuss the need for Alzheimer's researchers to account for SABV within preclinical studies.